ReNeuron's Cell Therapies Attract Fosun Pharma, A Leading Regenerative Medicines Developer

 
• By John Davis

The UK cell therapy biotech ReNeuron has attracted the healthcare group, Fosun Pharma, which is building up a leading position in regenerative medicine, to develop and commercialize its products in China.  

Shanghai
ReNeuron seals deal for China • Source: Shutterstock

More from Deals

More from Business